Europe Rifaximin Market Report 2016

December 2016 | 109 pages | ID: E0298C3C9D2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Rifaximin

Revenue, means the sales value of Rifaximin

This report studies sales (consumption) of Rifaximin in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Abbott Laboratories (US)
• Pharmos Corporation (US)
• Sucampo Pharmaceuticals, Inc. (US)
• Lexicon Pharmaceuticals (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Rifaximin in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Rifaximin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Rifaximin Market Report 2016

1 RIFAXIMIN OVERVIEW

1.1 Product Overview and Scope of Rifaximin
1.2 Classification of Rifaximin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Rifaximin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Rifaximin Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Rifaximin (2011-2021)
  1.5.1 Europe Rifaximin Sales and Growth Rate (2011-2021)
  1.5.2 Europe Rifaximin Revenue and Growth Rate (2011-2021)

2 EUROPE RIFAXIMIN BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Rifaximin Market Competition by Manufacturers
  2.1.1 Europe Rifaximin Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Rifaximin Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Rifaximin (Volume and Value) by Type
  2.2.1 Europe Rifaximin Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Rifaximin Revenue and Market Share by Type (2011-2016)
2.3 Europe Rifaximin (Volume and Value) by Countries
  2.3.1 Europe Rifaximin Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Rifaximin Revenue and Market Share by Countries (2011-2016)
2.4 Europe Rifaximin (Volume) by Application

3 GERMANY RIFAXIMIN (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Rifaximin Sales and Value (2011-2016)
  3.1.1 Germany Rifaximin Sales and Growth Rate (2011-2016)
  3.1.2 Germany Rifaximin Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Rifaximin Sales Price Trend (2011-2016)
3.2 Germany Rifaximin Sales and Market Share by Manufacturers
3.3 Germany Rifaximin Sales and Market Share by Type
3.4 Germany Rifaximin Sales and Market Share by Application

4 FRANCE RIFAXIMIN (VOLUME, VALUE AND SALES PRICE)

4.1 France Rifaximin Sales and Value (2011-2016)
  4.1.1 France Rifaximin Sales and Growth Rate (2011-2016)
  4.1.2 France Rifaximin Revenue and Growth Rate (2011-2016)
  4.1.4 France Rifaximin Sales Price Trend (2011-2016)
4.2 France Rifaximin Sales and Market Share by Manufacturers
4.3 France Rifaximin Sales and Market Share by Type
4.4 France Rifaximin Sales and Market Share by Application

5 UK RIFAXIMIN (VOLUME, VALUE AND SALES PRICE)

5.1 UK Rifaximin Sales and Value (2011-2016)
  5.1.1 UK Rifaximin Sales and Growth Rate (2011-2016)
  5.1.2 UK Rifaximin Revenue and Growth Rate (2011-2016)
  5.1.5 UK Rifaximin Sales Price Trend (2011-2016)
5.2 UK Rifaximin Sales and Market Share by Manufacturers
5.3 UK Rifaximin Sales and Market Share by Type
5.4 UK Rifaximin Sales and Market Share by Application

6 RUSSIA RIFAXIMIN (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Rifaximin Sales and Value (2011-2016)
  6.1.1 Russia Rifaximin Sales and Growth Rate (2011-2016)
  6.1.2 Russia Rifaximin Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Rifaximin Sales Price Trend (2011-2016)
6.2 Russia Rifaximin Sales and Market Share by Manufacturers
6.3 Russia Rifaximin Sales and Market Share by Type
6.4 Russia Rifaximin Sales and Market Share by Application

7 ITALY RIFAXIMIN (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Rifaximin Sales and Value (2011-2016)
  7.1.1 Italy Rifaximin Sales and Growth Rate (2011-2016)
  7.1.2 Italy Rifaximin Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Rifaximin Sales Price Trend (2011-2016)
7.2 Italy Rifaximin Sales and Market Share by Manufacturers
7.3 Italy Rifaximin Sales and Market Share by Type
7.4 Italy Rifaximin Sales and Market Share by Application

8 SPAIN RIFAXIMIN (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Rifaximin Sales and Value (2011-2016)
  8.1.1 Spain Rifaximin Sales and Growth Rate (2011-2016)
  8.1.2 Spain Rifaximin Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Rifaximin Sales Price Trend (2011-2016)
8.2 Spain Rifaximin Sales and Market Share by Manufacturers
8.3 Spain Rifaximin Sales and Market Share by Type
8.4 Spain Rifaximin Sales and Market Share by Application

9 BENELUX RIFAXIMIN (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Rifaximin Sales and Value (2011-2016)
  9.1.1 Benelux Rifaximin Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Rifaximin Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Rifaximin Sales Price Trend (2011-2016)
9.2 Benelux Rifaximin Sales and Market Share by Manufacturers
9.3 Benelux Rifaximin Sales and Market Share by Type
9.4 Benelux Rifaximin Sales and Market Share by Application

10 EUROPE RIFAXIMIN MANUFACTURERS ANALYSIS

10.1 Abbott Laboratories (US)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Rifaximin Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Abbott Laboratories (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Pharmos Corporation (US)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Rifaximin Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Pharmos Corporation (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Sucampo Pharmaceuticals, Inc. (US)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Rifaximin Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Sucampo Pharmaceuticals, Inc. (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Lexicon Pharmaceuticals (US)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Rifaximin Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Lexicon Pharmaceuticals (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview

11 RIFAXIMIN MANUFACTURING COST ANALYSIS

11.1 Rifaximin Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Rifaximin

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Rifaximin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Rifaximin Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE RIFAXIMIN MARKET FORECAST (2016-2021)

14.1 Germany Rifaximin Sales Forecast (2016-2021)
14.2 France Rifaximin Sales Forecast (2016-2021)
14.3 UK Rifaximin Sales Forecast (2016-2021)
14.4 Russia Rifaximin Sales Forecast (2016-2021)
14.5 Italy Rifaximin Sales Forecast (2016-2021)
14.6 Spain Rifaximin Sales Forecast (2016-2021)
14.7 Benelux Rifaximin Sales Forecast (2016-2021)
14.8 Europe Rifaximin Sales Forecast by Type (2016-2021)
14.9 Europe Rifaximin Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Rifaximin
Table Classification of Rifaximin
Figure Europe Sales Market Share of Rifaximin by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Rifaximin
Figure Europe Sales Market Share of Rifaximin by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Rifaximin Revenue and Growth Rate (2011-2021)
Figure France Rifaximin Revenue and Growth Rate (2011-2021)
Figure UK Rifaximin Revenue and Growth Rate (2011-2021)
Figure Russia Rifaximin Revenue and Growth Rate (2011-2021)
Figure Italy Rifaximin Revenue and Growth Rate (2011-2021)
Figure Spain Rifaximin Revenue and Growth Rate (2011-2021)
Figure Benelux Rifaximin Revenue and Growth Rate (2011-2021)
Figure Europe Rifaximin Sales and Growth Rate (2011-2021)
Figure Europe Rifaximin Revenue and Growth Rate (2011-2021)
Table Europe Rifaximin Sales of Key Manufacturers (2015 and 2016)
Table Europe Rifaximin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Rifaximin Sales Share by Manufacturers
Figure 2016 Rifaximin Sales Share by Manufacturers
Table Europe Rifaximin Revenue by Manufacturers (2015 and 2016)
Table Europe Rifaximin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Rifaximin Revenue Share by Manufacturers
Table 2016 Europe Rifaximin Revenue Share by Manufacturers
Table Europe Rifaximin Sales and Market Share by Type (2011-2016)
Table Europe Rifaximin Sales Share by Type (2011-2016)
Figure Sales Market Share of Rifaximin by Type (2011-2016)
Figure Europe Rifaximin Sales Growth Rate by Type (2011-2016)
Table Europe Rifaximin Revenue and Market Share by Type (2011-2016)
Table Europe Rifaximin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Rifaximin by Type (2011-2016)
Figure Europe Rifaximin Revenue Growth Rate by Type (2011-2016)
Table Europe Rifaximin Sales and Market Share by Countries (2011-2016)
Table Europe Rifaximin Sales Share by Countries (2011-2016)
Figure Sales Market Share of Rifaximin by Countries (2011-2016)
Table Europe Rifaximin Revenue and Market Share by Countries (2011-2016)
Table Europe Rifaximin Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Rifaximin by Countries (2011-2016)
Table Europe Rifaximin Sales and Market Share by Application (2011-2016)
Table Europe Rifaximin Sales Share by Application (2011-2016)
Figure Sales Market Share of Rifaximin by Application (2011-2016)
Figure Germany Rifaximin Sales and Growth Rate (2011-2016)
Figure Germany Rifaximin Revenue and Growth Rate (2011-2016)
Figure Germany Rifaximin Sales Price Trend (2011-2016)
Table Germany Rifaximin Sales by Manufacturers (2015 and 2016)
Table Germany Rifaximin Market Share by Manufacturers (2015 and 2016)
Table Germany Rifaximin Sales by Type (2015 and 2016)
Table Germany Rifaximin Market Share by Type (2015 and 2016)
Table Germany Rifaximin Sales by Application (2015 and 2016)
Table Germany Rifaximin Market Share by Application (2015 and 2016)
Figure France Rifaximin Sales and Growth Rate (2011-2016)
Figure France Rifaximin Revenue and Growth Rate (2011-2016)
Figure France Rifaximin Sales Price Trend (2011-2016)
Table France Rifaximin Sales by Manufacturers (2015 and 2016)
Table France Rifaximin Market Share by Manufacturers (2015 and 2016)
Table France Rifaximin Sales by Type (2015 and 2016)
Table France Rifaximin Market Share by Type (2015 and 2016)
Table France Rifaximin Sales by Application (2015 and 2016)
Table France Rifaximin Market Share by Application (2015 and 2016)
Figure UK Rifaximin Sales and Growth Rate (2011-2016)
Figure UK Rifaximin Revenue and Growth Rate (2011-2016)
Figure UK Rifaximin Sales Price Trend (2011-2016)
Table UK Rifaximin Sales by Manufacturers (2015 and 2016)
Table UK Rifaximin Market Share by Manufacturers (2015 and 2016)
Table UK Rifaximin Sales by Type (2015 and 2016)
Table UK Rifaximin Market Share by Type (2015 and 2016)
Table UK Rifaximin Sales by Application (2015 and 2016)
Table UK Rifaximin Market Share by Application (2015 and 2016)
Figure Russia Rifaximin Sales and Growth Rate (2011-2016)
Figure Russia Rifaximin Revenue and Growth Rate (2011-2016)
Figure Russia Rifaximin Sales Price Trend (2011-2016)
Table Russia Rifaximin Sales by Manufacturers (2015 and 2016)
Table Russia Rifaximin Market Share by Manufacturers (2015 and 2016)
Table Russia Rifaximin Sales by Type (2015 and 2016)
Table Russia Rifaximin Market Share by Type (2015 and 2016)
Table Russia Rifaximin Sales by Application (2015 and 2016)
Table Russia Rifaximin Market Share by Application (2015 and 2016)
Figure Italy Rifaximin Sales and Growth Rate (2011-2016)
Figure Italy Rifaximin Revenue and Growth Rate (2011-2016)
Figure Italy Rifaximin Sales Price Trend (2011-2016)
Table Italy Rifaximin Sales by Manufacturers (2015 and 2016)
Table Italy Rifaximin Market Share by Manufacturers (2015 and 2016)
Table Italy Rifaximin Sales by Type (2015 and 2016)
Table Italy Rifaximin Market Share by Type (2015 and 2016)
Table Italy Rifaximin Sales by Application (2015 and 2016)
Table Italy Rifaximin Market Share by Application (2015 and 2016)
Figure Spain Rifaximin Sales and Growth Rate (2011-2016)
Figure Spain Rifaximin Revenue and Growth Rate (2011-2016)
Figure Spain Rifaximin Sales Price Trend (2011-2016)
Table Spain Rifaximin Sales by Manufacturers (2015 and 2016)
Table Spain Rifaximin Market Share by Manufacturers (2015 and 2016)
Table Spain Rifaximin Sales by Type (2015 and 2016)
Table Spain Rifaximin Market Share by Type (2015 and 2016)
Table Spain Rifaximin Sales by Application (2015 and 2016)
Table Spain Rifaximin Market Share by Application (2015 and 2016)
Figure Benelux Rifaximin Sales and Growth Rate (2011-2016)
Figure Benelux Rifaximin Revenue and Growth Rate (2011-2016)
Figure Benelux Rifaximin Sales Price Trend (2011-2016)
Table Benelux Rifaximin Sales by Manufacturers (2015 and 2016)
Table Benelux Rifaximin Market Share by Manufacturers (2015 and 2016)
Table Benelux Rifaximin Sales by Type (2015 and 2016)
Table Benelux Rifaximin Market Share by Type (2015 and 2016)
Table Benelux Rifaximin Sales by Application (2015 and 2016)
Table Benelux Rifaximin Market Share by Application (2015 and 2016)
Table Rifaximin Basic Information List
Table Abbott Laboratories (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (US) Rifaximin Sales Market Share (2011-2016)
Table Pharmos Corporation (US) Basic Information List
Table Pharmos Corporation (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pharmos Corporation (US) Rifaximin Sales Market Share (2011-2016)
Table Sucampo Pharmaceuticals, Inc. (US) Basic Information List
Table Sucampo Pharmaceuticals, Inc. (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sucampo Pharmaceuticals, Inc. (US) Rifaximin Sales Market Share (2011-2016)
Table Lexicon Pharmaceuticals (US) Basic Information List
Table Lexicon Pharmaceuticals (US) Rifaximin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lexicon Pharmaceuticals (US) Rifaximin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rifaximin
Figure Manufacturing Process Analysis of Rifaximin
Figure Rifaximin Industrial Chain Analysis
Table Raw Materials Sources of Rifaximin Major Manufacturers in 2015
Table Major Buyers of Rifaximin
Table Distributors/Traders List
Figure Germany Rifaximin Sales and Growth Rate Forecast (2016-2021)
Figure Germany Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Figure France Rifaximin Sales and Growth Rate Forecast (2016-2021)
Figure France Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Figure UK Rifaximin Sales and Growth Rate Forecast (2016-2021)
Figure UK Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Rifaximin Sales and Growth Rate Forecast (2016-2021)
Figure Russia Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Rifaximin Sales and Growth Rate Forecast (2016-2021)
Figure Italy Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Rifaximin Sales and Growth Rate Forecast (2016-2021)
Figure Spain Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Rifaximin Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Rifaximin Revenue and Growth Rate Forecast (2016-2021)
Table Europe Rifaximin Sales Forecast by Type (2016-2021)
Table Europe Rifaximin Sales Forecast by Application (2016-2021)